Epacadostat (INCB024360) and indoximod (NLG8189 or 1-methyl-d-tryptophan) are the most common IDO inhibitors that are well tolerated and show obvious beneficial effects in cancer therapies; however, both have some major side effects. Here, IDO1 is linked to cancer.